Patients with SSc who tested positive for aPLs had a higher prevalence of unprovoked DVT/PE compared with aPL-negative patients.
LUND, SE / ACCESS Newswire / November 17, 2025 / BioInvent International AB ("BioInvent")(Nasdaq Stockholm: BINV)(STO:BINV), a biotech company focused on the discovery and development of novel and ...
The addition of neoadjuvant trastuzumab deruxtecan (T-DXd; Enhertu) significantly improved pathologic complete response (pCR) ...
7hon MSN
Life-saving whole blood program launched in Harford County for patients in transit to hospitals
Harford County launched a life-saving whole blood program that could increase the chances of survival for patients suffering ...
LUND, SE / ACCESS Newswire / November 18, 2025 / BioInvent International (STO:BINV):Most (78%) patients experienced disease control (stable disease), including heavily pretreated individuals with HER2 ...
Full Study Results Expected in Q1 2026Further Clinical Development of NAV-240 in Hidradenitis Suppurativa to Begin in Early ...
Respiratory syncytial virus (RSV) is a common respiratory virus which usually causes mild, cold-like symptoms during the ...
This retrospective cohort study used data from the Veterans Health Administration to assess the association between chronic untreated HCV and incident PDAC and whether different HCV genotypes affect ...
Spyre Therapeutics, Inc. (NASDAQ:SYRE) is one of the Hottest Small Cap Stocks to Buy Now. On November 4, Spyre Therapeutics, ...
LUND, SE / ACCESS Newswire / November 17, 2025 / BioInvent International AB ("BioInvent")(Nasdaq Stockholm: BINV)(STO:BINV), a biotech company focused on the discovery and development of novel and fir ...
Zymeworks surges on positive Phase 3 Ziihera data in HER2-positive cancer. Discover key catalysts and what’s next for ZYME stock.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback